PMA device
Sientra OPUS Silicone Gel Breast Implants
Tiger Aesthetics Medical, LLC · Prosthesis, Breast, Noninflatable, Internal, Silicone Gel-Filled (FTR, Class III) · First FDA decision Dec 1, 2017, newest May 26, 2023Breast reconstruction and augmentation
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
5
PMA pathway
Device trials
0
Naming "Sientra OPUS"
MAUDE reports
4,621
Brand "Sientra OPUS", since 2015
PubMed studies
0
Mentioning "Sientra OPUS"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Sientra OPUS Silicone Gel Breast Implants
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 5 of 5 decisions filed under this name.
- Sientra OPUS Silicone Gel Breast ImplantsPMA supplement
P070004-S018 · Decided May 26, 2023 · 1,513 days after receipt · Normal 180 Day Track No User Fee
Device type: Prosthesis, breast, noninflatable, internal, silicone gel-filled (FTR) · General & Plastic Surgery
- Sientra OPUS Silicone Gel Breast ImplantsPMA supplement
P070004-S033 · Decided Oct 27, 2021 · 82 days after receipt · Normal 180 Day Track
Device type: Prosthesis, breast, noninflatable, internal, silicone gel-filled (FTR) · General & Plastic Surgery
- Sientra OPUS Silicone Gel Breast ImplantsPMA supplement
P070004-S017 · Decided May 26, 2023 · 1,527 days after receipt · Normal 180 Day Track No User Fee
Device type: Prosthesis, breast, noninflatable, internal, silicone gel-filled (FTR) · General & Plastic Surgery
2 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Sientra OPUS", any status and sponsor, newest update first.
No registered device study names "Sientra OPUS".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Sientra OPUS", and for the whole product code for context.
This brand
4,621 reports: 2 malfunction, 4,619 injury, 0 death
Whole product code FTR
222,157 reports: 2,437 malfunction, 219,553 injury, 89 death
Newest reports for this brand
MW5157169 · Received Jul 10, 2024
Device type: Prosthesis, Breast, Noninflatable, Internal, Silicone Gel-Filled (FTR)
Patient problem as coded: Autoimmune Disorder; Emotional Changes; Fatigue; Unspecified Immune System Problem; Unspecified Gastrointestinal Problem
MW5157170 · Received Jul 10, 2024
Device type: Prosthesis, Breast, Noninflatable, Internal, Silicone Gel-Filled (FTR)
Patient problem as coded: Autoimmune Disorder; Fatigue; Failure of Implant; Unspecified Gastrointestinal Problem
MW5116102 · Received Mar 29, 2023 · Event dated Apr 18, 2022
Device type: Prosthesis, Breast, Noninflatable, Internal, Silicone Gel-Filled (FTR)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Chest Pain; Erythema; Fatigue; Headache; Pain; Anxiety; Sleep Dysfunction; Cognitive Changes; Eye Irritation
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Sientra OPUS"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code FTR.
- Natrelle Silicone-Filled Breast Implants and Natrelle INSPIRA Silicone-Filled Breast ImplantsAllergan · PMA 2026
- MemoryGel Silicone Gel-Filled Breast ImplantsMentor Corp. · PMA 2020
- MENTOR MemoryShape Breast ImplantsMentor Worldwide, LLC · PMA 2026
- MENTOR MemoryGel Breast ImplantsMentor Corp. · PMA 2026
- Sientra Silicone Gel Breast ImplantsTiger Aesthetics Medical, LLC · PMA 2024
- NATRELLE Highly Cohesive Anatomically Shaped Silicone-Filled Breast ImplantsAllergan · PMA 2021
- Natrelle 410 Highly Cohesive Anatomically Shaped Breast ImplantsAllergan · PMA 2015
- Motiva SmoothSilk Round Ergonomix Silicone Gel-Filled Breast ImplantsMotiva USA, LLC · PMA 2026
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.